Our Ratings and Bottom Line Hims & Hers offers a convenient online intake, clinician access, medication management, and home delivery through a familiar telehealth platform
Long-Term Weight Loss & Maintenance with Semaglutide in Obesity (2022 Review of STEP Trials) consolidates findings across multiple STEP trials (1, 3, 4, 8), showing 14.917.4% mean weight loss over 68 weeks, improved cardiometabolic markers, and better quality-of-life outcomes
Your doctor can put a prediabetes ICD-10 code on your record if you have prediabetes
GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives
In the landmark, large clinical studies of both semaglutide and tirzepatide for weight loss, participants took 1.7 or 2.4 mg of semaglutide and 5, 10, or 15 mg of tirzepatide